Skip to main content
. 2016 Jun 28;6:28712. doi: 10.1038/srep28712

Table 1. Study characteristics.

 
OSA
Control
Study Country No. Age Male (%) BMI AHI ESS No. Age Male (%) BMI AHI ESS NOS
Kamba et al.37 Japan 23 48.5 ± 12.9 82.6 (–) (–) (–) 15 45.7 ± 17.6 46.7 (–) (–) (–) 5
Alchanatis et al.35 Greece 22 49 ± 9.7 100 (–) 70.6 ± 19.4 8.2 ± 3.3 10 42.9 ± 10.5 100 (–) 3.4 ± 1.5 (–) 6
Alchanatis et al.35 Greece 14 48 ± 10.1 100 (–) 70.1 ± 19.8 8.4 ± 2.5 10 42.9 ± 10.5 100 (–) 3.4 ± 1.5 (–) 6
Bartlett et al.31 Australia 8 47.7 100 30.8 (–) (–) 5 51.8 (–) 25.0 (–) (–) 5
Halbower et al.26 America 6 11.5 ± 3.5 (–) 30.0 ± 6.2 37.9 ± 8.0 (–) 6 11.0 ± 2.3 (–) 20.9 ± 4.9 0.4 ± 0.2 (–) 5
Halbower et al.26 America 7 11.0 ± 3.1 (–) 29.4 ± 5.8 19.0 ± 9.9 (–) 6 11.0 ± 2.3 (–) 21.0 ± 4.8 0.2 ± 0.3 (–) 5
Tonon et al.30 Italy 14 48 ± 7 100 32.3 ± 4.6 (–) 13 ± 2 10 (–) 100 25 ± 2 (–) (–) 5
Sarchielli et al.29 Italy 20 52.7 ± 11.0 65 26.4 ± 2.1 16.7 ± 15.0 11.7 ± 1.7 20 51.4 ± 13.2 70 22.1 ± 3.4 2.7 ± 0.3 4.4 ± 0.8 5
Sharma et al.38 India 18 48.0 ± 8.8 66.7 30.0 ± 5.5 46.7 ± 29.8 12 ± 5.6 32 39.9 ± 10.2 65.6 27.2 ± 5.9 0.9 ± 1.3 5.5 ± 4.1 5
Algin et al.33 Turkey 24 52 95.8 (–) 56 ± 8 (–) 9 48 66.7 (–) <5 (–) 5
O’Donoghue et al.32 Australia 30 45.2 ± 9.6 100 33.3 ± 4.6 71.5 ± 16.2 12.9 ± 4.3 23 41.3 ± 9.3 100 25.6 ± 2.9 5.3 ± 3.9 5.2 ± 3.4 6
Gharraf et al.36 Egypt 15 48.1 ± 6.9 73.3 47.3 ± 13.5 65.5 ± 20.3 17.7 ± 2.5 10 49.1 ± 7.6 70 26.2 ± 2.1 2.7 ± 1.2 3.4 ± 1.2 6
Kizilgoz et al.34 Turkey 20 47.7 ± 11.6 75 (–) 29.3 ± 21 (–) 5 43.8 ± 2.6 20 (–) 4 ± 0.88 (–) 4
Yadav et al.28 America 36 48 ± 9.3 77.8 30.6 ± 5.9 30.6 ± 5.9 9.9 ± 4.9 53 46.8 ± 8.1 60.4 24.7 ± 3.8 (–) 5.7 ± 3.3 5
Macey et al.27 America 14 47.5 ± 10.5 64.2 (–) 29.5 ± 15.6 (–) 22 47.5 ± 10.1 50 (–) (–) (–) 4

Abbreviations: OSA, Obstructive sleep apnea; No., number of enrolled subjects; Male (%), percentage of male subjects; AHI, Apnea/Hypopnea Index; BMI, Body Mass Index; ESS, Epworth Sleepiness Score; NOS, Newcastle–Ottawa Scale.